Company Valuation: TELCON RF PHARMACEUTICAL. Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 517,387 255,964 110,233 97,672 70,587 62,827
Change - -50.53% -56.93% -11.39% -27.73% -10.99%
Enterprise Value (EV) 1 580,973 288,705 130,775 114,577 116,241 64,971
Change - -50.31% -54.7% -12.39% 1.45% -44.11%
P/E -12x -11.1x -2.56x 8.52x -2.64x -3.84x
PBR 5.81x 2.74x 1.31x 0.97x 0.85x 0.58x
PEG - 0.2x -0.1x -0x 0x 0.1x
Capitalization / Revenue 15.6x 6.76x 3.96x 2.69x 1.86x 1.46x
EV / Revenue 17.5x 7.63x 4.7x 3.16x 3.07x 1.51x
EV / EBITDA 252x -795x 599x 22x 26.2x 11.7x
EV / EBIT -278x -63.3x -32.2x 119x -1,648x 90.4x
EV / FCF -562x -37.4x 414x -21.5x 11.2x -7.31x
FCF Yield -0.18% -2.67% 0.24% -4.64% 8.9% -13.7%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -16,772 -8,764 -13,233 3,417 -7,417 -2,390
Distribution rate - - - - - -
Net sales 1 33,141 37,841 27,830 36,307 37,865 43,162
EBITDA 1 2,307 -363.1 218.5 5,210 4,436 5,543
EBIT 1 -2,090 -4,563 -4,063 965.3 -70.55 718.6
Net income 1 -40,893 -23,098 -42,084 13,906 -26,320 -11,456
Net Debt 1 63,586 32,741 20,542 16,904 45,654 2,143
Reference price 2 202,000.00 97,500.00 33,833.33 29,100.00 19,566.67 9,170.00
Nbr of stocks (in thousands) 2,561 2,625 3,258 3,356 3,608 6,851
Announcement Date 3/22/21 3/22/22 3/21/23 3/19/24 3/18/25 3/19/26
1KRW in Million2KRW
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 10.37M
34.43x7.21x18.62x1.48% 441B
49.99x16.96x35.41x-.--% 212B
18.77x0.78x13.6x2.39% 169B
34.62x10.54x26.2x0.3% 161B
31.16x5.94x17.38x1.15% 68.61B
148.36x19.1x56.01x-.--% 57.01B
35.2x2.23x14.46x1.7% 56.83B
71.93x8.38x38.68x-.--% 53B
26.32x5.7x19.72x1.65% 48.13B
Average 50.09x 8.54x 26.68x 0.96% 126.69B
Weighted average by Cap. 41.22x 8.65x 24.04x 1.07%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. A200230 Stock
  4. Valuation TELCON RF PHARMACEUTICAL. Inc.